replacement therapy (hemodialysis, peritoneal dialysis, or renal transplantation) for survival. Patients with ESRD currently comprise only a small proportion of patients undergoing lower extremity arterial reconstructions (6% in our institution), but this may change dramatically in the future. In 1998, approximately 300,000 patients were receiving renal replacement therapy in the United StatesB that number is growing at an annual rate 6 to 7%2 and will reach an estimated 600,000 patients by 2010 .~ The greatest increase in treatment with long-term dialysis has been among the elderly and those with diabetes, two groups at high risk for peripheral arterial occlusive disease (PAOD). 4, 5 In addition, over the last 2 decades, the life expectancy of dialysis patients has slowly improved, resulting in an older population with potentially more advanced atherosclerotic disease. 4 These data suggest an increasing burden of PAOD in patients with ESRD and a concomitant rise in future demand for arterial reconstruction.
Since the late 1980s, ESRD ESRD (Fig. 1 A,B) . Part 
